FindTrial
Sign In

Mechanism of Hsa_circ_0075961 promoting invasion and metastasis of laryngeal squamous cell carcinoma cells

Mechanism of Hsa_circ_0075961 promoting invasion and metastasis of laryngeal squamous cell carcinoma cells

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500095618
Enrollment
Unknown
Registered
2025-01-09
Start date
2025-01-10
Completion date
Unknown
Last updated
2025-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Laryngeal cancer

Interventions

Laryngeal squamous cell carcinoma group:N/A
Paralaryngeal squamous cell carcinoma tissue group:N/A

Sponsors

The First Hospital of Shanxi Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: 1. The patients with laryngeal squamous cell carcinoma were initially diagnosed and did not receive radiotherapy, chemotherapy or biological therapy; 2. The patient has no hereditary family history, no other major diseases, no history of syphilis, tuberculosis, HIV, HPV, HBV and other infections; 3. Normal tissues adjacent to cancer should be confirmed without tumor cells by pathology; 4. Sign the informed consent.

Exclusion criteria

Exclusion criteria: 1. Have other tumors except laryngeal squamous cell carcinoma. 2. Fail to comply with the follow-up study of this project.

Design outcomes

Primary

MeasureTime frame
circ_0075961;zinc finger E-box-binding homeobox protein 1, ZEB1;—

Countries

China

Contacts

Public ContactSen Zhang

The First Hospital of Shanxi Medical University

cccsl@163.com+86 139 9420 0909

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026